Thurston, Springer, Miller, Herd & Titak, Inc. Inotiv, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $730 Million
- Q2 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Inotiv, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 177,725 shares of NOTV stock, worth $355,450. This represents 0.04% of its overall portfolio holdings.
Number of Shares
177,725
Previous 122,167
45.48%
Holding current value
$355,450
Previous $262,000
23.28%
% of portfolio
0.04%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding NOTV
# of Institutions
80Shares Held
8.19MCall Options Held
66.9KPut Options Held
125K-
Balyasny Asset Management LLC Chicago, IL1.65MShares$3.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.77 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny398KShares$795,9080.0% of portfolio
-
Massar Capital Management, LP Stamford, CT350KShares$700,0000.48% of portfolio
-
Vantage Point Financial LLC Lisle, IL337KShares$673,0920.27% of portfolio
About Inotiv, Inc.
- Ticker NOTV
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 25,594,500
- Market Cap $51.2M
- Description
- Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...